anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BioAtla · pitchdeck

BioAtla | Investor Presentation Deck | 40 slides

40 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

BioAtla | Investor Presentation Deck | 40 slides

BioAtla · 2022-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 24 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 13 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides · 4 hits 100% 3/3 slides Solution 3 slides 100% 3/3 slides 100% 3/3 slides · 13 hits
— 0/3 slides
66.7% 2/3 slides 66.7% 2/3 slides 100% 3/3 slides · 4 hits 33.3% 1/3 slides Traction 11 slides 100% 11/11 slides 100% 11/11 slides · 56 hits
— 0/11 slides
27.3% 3/11 slides 18.2% 2/11 slides 100% 11/11 slides · 17 hits 100% 11/11 slides Market Size 7 slides 100% 7/7 slides 100% 7/7 slides · 35 hits
— 0/7 slides
14.3% 1/7 slides 28.6% 2/7 slides 100% 7/7 slides · 13 hits 85.7% 6/7 slides

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a connected circle diagram to represent the company's key pillars.summarize
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
other
Open slide detailBeat · ProblemLoop · Cost Of Inaction
05
Uses a visual comparison framework to contrast healthy cells (no binding) vs cancer cells (binding).present_solution
Open slide detailBeat · ProblemLoop · Cost Of Inaction
06
The slide uses a three-column layout to illustrate the versatility of the CAB platform across different therapeutic mechanisms.present_solution
Open slide detailBeat · Solution
07
The slide uses a Gantt-style visualization to show the clinical stage of drug candidates.plan_implementation
Open slide detailBeat · Solution
08
transition
Open slide detail
09
The slide uses a structured list format to contrast the specific opportunity in UPS with the broader landscape of other sarcoma subtypes.size_opportunity
Open slide detailBeat · Market Size
10
Includes waterfall plot for partial response and spider plot for longitudinal tumor change.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
11
The slide uses a hierarchical tree structure to map patient cohorts to their respective clinical outcomes and advancement decisions.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
12
Includes 'Number at Risk' table below the Kaplan-Meier plot.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
13
Includes specific clinical trial safety metrics (AEs, SAEs, CTCAE grades).show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
14
summarize
Open slide detailBeat · TractionLoop · Quick Win Big Bet
15
The slide uses a 2x2 grid of metrics to frame the market opportunity, followed by specific target population and success threshold data.size_opportunity
Open slide detailBeat · TractionLoop · Quick Win Big Bet
16
The chart displays maximum change from baseline for four distinct patient cohorts/scenarios.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
17
The slide uses a process-oriented layout to describe clinical trial phases.plan_implementation
Open slide detailBeat · TractionLoop · Quick Win Big Bet
18
Data cut-off Oct 28, 2022. Includes definitions for W/D, NSQ, SQ, and response markers.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
19
Waterfall plot showing clinical response (PD, SD, PR, CR) for patients treated with BA3011.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
20
Data presented in a table format comparing BA3011 (N=13) and BA3011 + Opdivo (N=9).show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
21
transition
Open slide detail
22
The slide uses a grid of metrics to define the addressable market and clinical success thresholds.size_opportunity
Open slide detail
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.show_traction
Open slide detail
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population sizing.size_opportunity
Open slide detail
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.show_traction
Open slide detail
26
The slide uses a combination of big numbers and bulleted lists to frame the market opportunity and clinical unmet need.size_opportunity
Open slide detail
27
The slide uses a table to present clinical outcomes (PR/CR) for specific tumor types, supporting the 'first-in-class' claim.show_traction
Open slide detail
28
The slide uses a process-flow layout to describe clinical trial progression.plan_implementation
Open slide detail
29
transition
Open slide detail
30
The slide uses a combination of a comparison table for clinical data and a dot plot for NHP toxicity data.compare_peers
Open slide detail
31
The slide uses a timeline-based visualization to show dose escalation steps. RP2D = Recommended Phase 2 Dose. DLT = Dose Limiting Toxicity.plan_implementation
Open slide detail
32
transition
Open slide detail
33
Uses a before-after-bridge style framing (problem on left, solution/results on right).present_solution
Open slide detail
34
The slide uses a process flow diagram to illustrate clinical trial dose escalation cohorts.present_framework
Open slide detail
35
The slide uses a table-based timeline format to map specific clinical trial phases to programs and indications.plan_implementation
Open slide detail
36
The slide uses a linked-circle diagram to represent the company's key pillars.summarize
Open slide detail
37
appendix
Open slide detail
38
other
Open slide detail
39
Includes a Kaplan-Meier survival curve and a summary table of clinical outcomes.show_traction
Open slide detail
40
Includes Kaplan-Meier plots with embedded data tables for two distinct patient cohorts.show_traction
Open slide detail